PT1197223E - Preventivos/medicamentos/inibidores da progressao de retinopatia simples ou retinopatia pre-proliferativa - Google Patents

Preventivos/medicamentos/inibidores da progressao de retinopatia simples ou retinopatia pre-proliferativa

Info

Publication number
PT1197223E
PT1197223E PT00921056T PT00921056T PT1197223E PT 1197223 E PT1197223 E PT 1197223E PT 00921056 T PT00921056 T PT 00921056T PT 00921056 T PT00921056 T PT 00921056T PT 1197223 E PT1197223 E PT 1197223E
Authority
PT
Portugal
Prior art keywords
retinopathy
preventive
medicines
inhibitors
progression
Prior art date
Application number
PT00921056T
Other languages
English (en)
Inventor
Hitoshi Ikeda
Shizue Nakagawa
Nagisa Yasutaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of PT1197223E publication Critical patent/PT1197223E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00921056T 1999-04-28 2000-04-27 Preventivos/medicamentos/inibidores da progressao de retinopatia simples ou retinopatia pre-proliferativa PT1197223E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12149899 1999-04-28

Publications (1)

Publication Number Publication Date
PT1197223E true PT1197223E (pt) 2005-04-29

Family

ID=14812676

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00921056T PT1197223E (pt) 1999-04-28 2000-04-27 Preventivos/medicamentos/inibidores da progressao de retinopatia simples ou retinopatia pre-proliferativa

Country Status (23)

Country Link
US (2) US7064141B1 (pt)
EP (1) EP1197223B1 (pt)
KR (1) KR100865059B1 (pt)
CN (1) CN1172719C (pt)
AT (1) ATE289204T1 (pt)
AU (1) AU774799B2 (pt)
BR (1) BR0010084A (pt)
CA (1) CA2371554C (pt)
CZ (1) CZ301913B6 (pt)
DE (1) DE60018186T2 (pt)
DK (1) DK1197223T3 (pt)
ES (1) ES2233362T3 (pt)
HU (1) HU226948B1 (pt)
MX (1) MXPA01010923A (pt)
NO (1) NO327446B1 (pt)
NZ (1) NZ514855A (pt)
PL (1) PL196895B1 (pt)
PT (1) PT1197223E (pt)
RU (1) RU2239454C2 (pt)
SI (1) SI1197223T1 (pt)
SK (1) SK286859B6 (pt)
WO (1) WO2000066161A1 (pt)
ZA (1) ZA200108527B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4484427B2 (ja) * 2001-12-03 2010-06-16 武田薬品工業株式会社 インスリン抵抗性改善剤
WO2003047573A1 (fr) * 2001-12-03 2003-06-12 Takeda Chemical Industries, Ltd. Agents pour améliorer l'état de résistance à l'insuline
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US8980870B2 (en) 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas
US20050038093A1 (en) * 2003-05-02 2005-02-17 Boehringer Ingelheim International Gmbh Treating diabetic retinopathy with angiotensin II receptor blockers
PL1784181T3 (pl) * 2004-08-31 2013-10-31 Newsouth Innovations Pty Ltd Zahamowanie czynnika wzrostu śródbłonka naczyniowego
EA013053B1 (ru) * 2004-11-05 2010-02-26 Бёрингер Ингельхайм Интернациональ Гмбх Двуслойная таблетка, содержащая телмисартан и амлодипин
WO2006115185A1 (ja) * 2005-04-21 2006-11-02 Santen Pharmaceutical Co., Ltd. 角結膜障害治療剤
KR20080074128A (ko) * 2005-12-06 2008-08-12 산텐 세이야꾸 가부시키가이샤 각결막 장애 치료제
EA016593B1 (ru) * 2007-03-28 2012-06-29 Такеда Фармасьютикал Компани Лимитед ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ПРОИЗВОДНОЕ БЕНЗИМИДАЗОЛ-7-КАРБОКСИЛАТА И pH РЕГУЛИРУЮЩИЙ АГЕНТ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027211D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
US5591762A (en) 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4201554A1 (de) 1992-01-22 1993-07-29 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB9110635D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma
GB9223860D0 (en) * 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
JPH0789957A (ja) * 1993-09-22 1995-04-04 Nissan Chem Ind Ltd ビフェニルメチルアミン誘導体
WO1995021609A1 (en) 1994-02-08 1995-08-17 Ciba-Geigy Ag Treatment of normotensive glaucoma with angiotensin ii antagonists
JPH09210183A (ja) * 1996-01-31 1997-08-12 Suzuki Motor Corp 動力伝達装置
BR9708336A (pt) * 1996-03-29 1999-08-03 Smithkline Beecham Corp Diidrato de eprosartan e processo para sua produção e formulação
SK283348B6 (sk) 1996-04-05 2003-06-03 Takeda Chemical Industries, Ltd. Farmaceutický prípravok obsahujúci zlúčeninu s antagonickým účinkom na angiotenzín II
TW416953B (en) * 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
EP0855392A3 (de) 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2294515C (en) * 1997-06-27 2007-08-28 Smithkline Beecham Corporation Eprosartan monohydrate
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
ES2273433T3 (es) * 1997-08-06 2007-05-01 Smithkline Beecham Corporation Complejo por neutralizacion de cargas con arginilo de eprosartan y procedimiento para su produccion y formulacion.
CN1291888A (zh) 1998-03-04 2001-04-18 武田药品工业株式会社 Aⅱ拮抗剂的缓释制剂、其制备和用途
PT1096932E (pt) 1998-07-10 2007-09-21 Novartis Pharma Ag ''combinação anti-hipertensiva de valsartan e bloqueadores do canal de cálcio''
FR2783422A1 (fr) * 1998-09-21 2000-03-24 Sanofi Sa Composition pharmaceutique contenant un antagoniste des recepteurs at1 de l'angiotensine ii et un antiagregant plaquettaire
JP2000159671A (ja) * 1998-12-01 2000-06-13 Takeda Chem Ind Ltd 血管新生阻害剤

Also Published As

Publication number Publication date
ATE289204T1 (de) 2005-03-15
KR20020015315A (ko) 2002-02-27
MXPA01010923A (es) 2002-06-21
CZ301913B6 (cs) 2010-07-28
ZA200108527B (en) 2002-10-17
SK15452001A3 (sk) 2002-04-04
SK286859B6 (sk) 2009-06-05
ES2233362T3 (es) 2005-06-16
US20060189669A1 (en) 2006-08-24
PL350554A1 (en) 2002-12-16
RU2239454C2 (ru) 2004-11-10
EP1197223A1 (en) 2002-04-17
US7064141B1 (en) 2006-06-20
AU4143400A (en) 2000-11-17
NZ514855A (en) 2004-01-30
SI1197223T1 (pt) 2005-08-31
EP1197223B1 (en) 2005-02-16
NO20015257L (no) 2001-10-26
PL196895B1 (pl) 2008-02-29
CA2371554C (en) 2009-06-09
EP1197223A4 (en) 2003-10-29
DK1197223T3 (da) 2005-05-30
DE60018186D1 (de) 2005-03-24
AU774799B2 (en) 2004-07-08
CN1172719C (zh) 2004-10-27
KR100865059B1 (ko) 2008-10-23
CZ20013804A3 (cs) 2002-04-17
CN1348385A (zh) 2002-05-08
DE60018186T2 (de) 2005-12-29
HU226948B1 (en) 2010-03-29
CA2371554A1 (en) 2000-11-09
WO2000066161A1 (fr) 2000-11-09
HUP0200890A2 (hu) 2002-11-28
NO327446B1 (no) 2009-06-29
BR0010084A (pt) 2002-01-15
HUP0200890A3 (en) 2002-12-28
NO20015257D0 (no) 2001-10-26

Similar Documents

Publication Publication Date Title
BR0109703A (pt) Derivados de piperazina
ATE538794T1 (de) Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
AR037595A1 (es) Metodos de tratamiento y formulaciones de cefalosporina
GB9801690D0 (en) Therapeutic agents
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
DE60005054D1 (de) Chinuclidin-acrylamide
BR0208956A (pt) Abridor de canais de k ativados por cálcio de grande condutância
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
PT1197223E (pt) Preventivos/medicamentos/inibidores da progressao de retinopatia simples ou retinopatia pre-proliferativa
ATE356817T1 (de) Therapeutische piperazin verbindungen.
ATE362758T1 (de) Indomethacin-amidderivate zur antiangiogenen und/oder antitumorigen verwendung
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
PT1002533E (pt) Utilizacao de derivados de cromanos e/ou cromenos para prevenir reaccoes oxidativas induzidas por radicais livres
BR0109542A (pt) Derivados de imidazopirina alquilados
BR0114697A (pt) Derivados em ponte de piperazina
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
DE69925270D1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
HUP9904030A2 (hu) Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
BR0201288A (pt) Derivados de piperazina